Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  eflornithine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 5 to 45
Sponsor: NCI
Protocol IDs: NCOG-6G871, BTRC-8625, MDA-DM-88056, NCI-T86-0226D, T86-0226

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: BTRC-6G901, NCI-T91-0047O, T91-0047

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-92035, NCI-T92-0114C, T92-0114

4.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365

5.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067928, U01CA077158, WCCC-CO-9737, NCI-P00-0155, NCT00005884

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8525A, NCI-T85-0043D, T85-0043

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-84-C-179, NCI-T84-0477N, T84-0477

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: RPMI-PPC-764, NCI-T83-0886D

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-88130, NCI-T88-0236H, T88-0236

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-867202, NCI-T89-0006C, T89-0006

11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-895151, EST-C-0490, MAYO-895151, I89-0001, NCI-P91-0008

12.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: Other
Protocol IDs: UCI-DFMO/COLON, NCI-P92-0007

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353198, UAB-9921, UAB-F990728039, NCT00086736

14.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: 2001-414, CO00318, NCT00204789

15.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882

16.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068767, P01CA027502, UARIZ-HSC-0072, NCI-H01-0075, NCT00021294

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: JHH-82062901, NCI-T83-1142W, T83-1142

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-860301, NCI-T89-0005C, T89-0005

19.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-89105, NCI-T89-0213D, T89-0213

20.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 50 to 65
Sponsor:
Protocol IDs: UARIZ-8948, NCI-P92-0011

21.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: WCCC-CO-9134, NCI-P92-0022

22.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: NMTRC 002, NCT01059071

23.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: NCOG-4P843, NCOG-4P-84-3
New Search